BECN1 and melanoma: In models of mouse melanoma tumors, animals with Beclin-1 (+/−) showed a more aggressive tumor growth and increased angiogenic activity, compared to mice with Beclin-1 wild-type, by boosting the protein expression and stability of hypoxia-inducible factor-2α (HIF-2α) (250).